The current financial score of Core Laboratories Inc is 7.73. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 132.08M, representing a year-over-year decrease of 1.82%, while its net profit experienced a year-over-year decrease of 61.77%.
The current valuation score of Core Laboratories Inc is 7.84. Its current P/E ratio is 14.57, which is 334.00% below the recent high of 63.24 and 2.96% above the recent low of 14.14.
The current earnings forecast score of Core Laboratories Inc is 6.67. The average price target is 14.67, with a high of 20.00 and a low of 11.00.
The current price momentum score of Core Laboratories Inc is 4.16. Currently, the stock price is trading between the resistance level at 10.39 and the support level at 8.22, making it suitable for range-bound swing trading.
The current institutional shareholding score of Core Laboratories Inc is 10.00. The latest institutional shareholding proportion is 111.85%, representing a quarter-over-quarter decrease of 9.75%.
The current risk assessment score of Core Laboratories Inc is 5.70. The company's beta value is 0.99. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.